Descriptions

Mob1 is an activator of large tumor suppressor 1/2 (LATS1/2) in the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. Mob1b adopts an autoinhibited, closed conformation, with its N-terminal region. Truncation of N-terminal region (1-32), which removes most of the Switch helix, enhances binding of Mob1b to the NTR domain of LATS1. Phosphomimetic substitution of Thr12 and Thr35 with an aspartate residue also induces enhancement of LATS1 binding. Specifically, the N-terminal extension comprising a positively-charged region followed by Switch α-helix (20-39) binds directly to the LATS1-binding surface to block LATS1 binding and this blocking is stabilized by β-sheet formation between SN strand (5-9) of the N-terminal extension and S2 strand (94-98) of the core domain. The H1 helix of the autoinhibited form is followed by a sharp turn of Ser38-Gly39 and the Switch helix. The turn is stabilized by the Ser38 side chain forming hydrogen bonds with the main chains of Thr35 from the H1 helix and Asn40 from the Switch helix. This turn is absent in the phosphorylated form and the peptide chain is extended to run through the shallow groove formed by helices H6-H7 and H9 and is followed by a disordered region. The extended structure is stabilized by Ser38 interacting with the phosphate group of Thr35 and a short 310-helix (H0) formed by Leu-Leu-Lys at positions 28–30, which bind the hydrophobic site of the shallow groove. In the autoinhibited form, the Leu-Leu-Lys segment is part of the Switch helix and two Leu residues participate in nonpolar interactions with the H2 helix. The phosphorylated Thr12 residue of the pMOB1A-LATS1 complex is located close to the S2 strand so that the phosphate group is docked into the basic cluster pocket. The N-terminal end residues (1-9) are disordered but the three residues (13-15) that follow pThr12 form the S0 strand, which associates with the S2 strand to form a short antiparallel β-sheet. This S0-S2 β-sheet formation differs from that of the SN-S2 β-sheet found in the autoinhibited form in several ways. First, the SN strand of the autoinhibited form is formed by five residues and is longer than the S0 strand. Second, the residues forming the SN strand are located at positions 5-9 (Phe5 to Ser9) and represent a 6-residue shift toward the N-terminal end. It is likely that on phosphorylation, the peptide chain of the N-terminal extension is pulled down toward the basic cluster pocket for phosphorylated Thr12 binding, resulting in a frame shift of residues forming the β-strand associated with the S2 strand. This shift should induce dissociation of the Switch helix, which is also accelerated by phosphorylation of Thr35 located at the helix. This mechanism is called as the pull-the-string mechanism for MOB1 activation.

Autoinhibitory domains (AIDs)

Target domain

41-204 (MH domain)

Relief mechanism

PTM

Assay

Mutagenesis experiment, Deletion assay, Structural analysis

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

4 structures for Q8BPB0

Entry ID Method Resolution Chain Position Source
5B5V X-ray 219 A A/B/C/D/E/F 1-216 PDB
5B5W X-ray 296 A A 33-216 PDB
5B6B X-ray 354 A A/B/D/F/H/K/M/O 1-216 PDB
AF-Q8BPB0-F1 Predicted AlphaFoldDB

10 variants for Q8BPB0

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388739756 19 I>K No EVA
rs3388769164 72 Y>C No EVA
rs3388773158 79 C>Y No EVA
rs3388761926 103 I>K No EVA
rs3388751422 105 K>R No EVA
rs3388769144 114 Y>* No EVA
rs3388768217 135 K>Q No EVA
rs3395868091 157 R>* No EVA
rs3395750203 159 Y>F No EVA
rs3388765789 183 F>S No EVA

No associated diseases with Q8BPB0

3 regional properties for Q8BPB0

Type Name Position InterPro Accession
domain W2 domain 720 - 904 IPR003307
domain MIF4G-like, type 3 78 - 308 IPR003890
domain Initiation factor eIF-4 gamma, MA3 543 - 666 IPR003891

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Nucleus
PANTHER Family PTHR22599 MPS ONE BINDER KINASE ACTIVATOR-LIKE MOB
PANTHER Subfamily PTHR22599:SF63 MOB KINASE ACTIVATOR 1B
PANTHER Protein Class kinase modulator
kinase activator
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

4 GO annotations of molecular function

Name Definition
kinase activator activity Binds to and increases the activity of a kinase, an enzyme which catalyzes of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
kinase binding Binding to a kinase, any enzyme that catalyzes the transfer of a phosphate group.
metal ion binding Binding to a metal ion.
protein kinase activator activity Binds to and increases the activity of a protein kinase, an enzyme which phosphorylates a protein.

3 GO annotations of biological process

Name Definition
hippo signaling The series of molecular signals mediated by the serine/threonine kinase Hippo or one of its orthologs. In Drosophila, Hippo in complex with the scaffold protein Salvador (Sav), phosphorylates and activates Warts (Wts), which in turn phosphorylates and inactivates the Yorkie (Yki) transcriptional activator. The core fly components hippo, sav, wts and mats are conserved in mammals as STK4/3 (MST1/2), SAV1/WW45, LATS1/2 and MOB1.
positive regulation of protein phosphorylation Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
regulation of protein autophosphorylation Any process that modulates the frequency, rate or extent of addition of the phosphorylation by a protein of one or more of its own residues.

12 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P43563 MOB2 CBK1 kinase activator protein MOB2 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
P40484 MOB1 DBF2 kinase activator protein MOB1 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) SS
Q95RA8 mats MOB kinase activator-like 1 Drosophila melanogaster (Fruit fly) SS
Q9H8S9 MOB1A MOB kinase activator 1A Homo sapiens (Human) EV
Q7L9L4 MOB1B MOB kinase activator 1B Homo sapiens (Human) SS
Q8BSU7 Mob3a MOB kinase activator 3A Mus musculus (Mouse) SS
Q8BJG4 Mob3c MOB kinase activator 3C Mus musculus (Mouse) SS
Q8VE04 Mob3b MOB kinase activator 3B Mus musculus (Mouse) SS
Q921Y0 Mob1a MOB kinase activator 1A Mus musculus (Mouse) SS
Q3T1J9 Mob1a MOB kinase activator 1A Rattus norvegicus (Rat) SS
Q8GYX0 MOB1B MOB kinase activator-like 1B Arabidopsis thaliana (Mouse-ear cress) SS
Q9FHI1 MOB1A MOB kinase activator-like 1A Arabidopsis thaliana (Mouse-ear cress) SS
10 20 30 40 50 60
MSFLFGSRSS KTFKPKKNIP EGSHQYELLK HAEATLGSGN LRMAVMLPEG EDLNEWVAVN
70 80 90 100 110 120
TVDFFNQINM LYGTITDFCT EESCPVMSAG PKYEYHWADG TNIKKPIKCS APKYIDYLMT
130 140 150 160 170 180
WVQDQLDDET LFPSKIGVPF PKNFMSVAKT ILKRLFRVYA HIYHQHFDPV IQLQEEAHLN
190 200 210
TSFKHFIFFV QEFNLIDRRE LAPLQELIEK LTSKDR